尿液游离DNA检测结核病的研究进展与前景
本文评论Oreskovic等在J Clin Microbiol发表的一项优化尿液游离DNA(cfDNA)检测结核病(TB)的研究。该回顾性研究使用南非活动性肺结核患者的冻存尿样(n=73),采用序列特异性纯化联合短靶标PCR技术。总体灵敏度83.7%(95%CI:71.0-91.5),特异度100%(95%CI:86.2-100),达到WHO性能标准。
要点
- 优化尿液cfDNA检测TB灵敏度83.7%、特异度100%,达WHO标准
- 非HIV感染者灵敏度73.3%,涂阴TB患者灵敏度76%
- 该技术有望成为非痰液TB诊断方法,需进一步研究验证
核心结论
- 优化尿液cfDNA检测在早期验证中达到WHO性能标准,是非痰液TB诊断的有前景方法。
研究设计与样本
- 回顾性临床研究,使用南非活动性肺结核患者冻存尿样(n=73),与非TB患者对比,采用序列特异性纯化联合短靶标PCR。
主要发现
- 总体灵敏度83.7%(95%CI:71.0-91.5),特异度100%(95%CI:86.2-100)。
- 非HIV感染者灵敏度73.3%(95%CI:48.1-89.1),涂阴TB患者灵敏度76%(95%CI:56.5-88.5)。
关键数值与推荐
- 灵敏度83.7%(95%CI:71.0-91.5)和特异度100%(95%CI:86.2-100)满足WHO发布的性能标准。
临床怎么用
- 该检测可作为非痰液TB诊断的潜在工具,尤其适用于难以获取痰液样本的患者。
局限性
- 样本量较小(n=73),为回顾性研究,需进一步在前瞻性研究中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A highly accurate, non-sputum-based test for tuberculosis (TB) detection is a key priority for the field of TB diagnostics. A recent study in the Journal of Clinical Microbiology by Oreskovic and colleagues (J Clin Microbiol 59:e00074-21, 2021, https://doi.org/10.1128/JCM.00074-21) reports the performance of an optimized urine cell-free DNA (cfDNA) test using sequence-specific purification combined with short-target PCR to improve the accuracy of TB detection. Their retrospective clinical study utilized frozen urine samples (n = 73) from study participants diagnosed with active pulmonary TB in South Africa and compared results to non-TB patients in South Africa and the United States in an early-phase validation study. Overall, this cfDNA technique detected TB with a sensitivity of 83.7% (95% CI: 71.0 to 91.5) and specificity of 100% (95% CI: 86.2 to 100), which meet the World Health Organization's published performance criteria. Sensitivity was 73.3% in people without HIV (95% CI: 48.1 to 89.1) and 76% in people with smear-negative TB (95% CI: 56.5 to 88.5). In this commentary, we discuss the results of this optimized urine TB cfDNA assay within the larger context of TB diagnostics and pose additional questions for further research.
引用
- MacLean E, Nathavitharana RR. Progress toward Developing Sensitive Non-Sputum-Based Tuberculosis Diagnostic Tests: the Promise of Urine Cell-Free DNA. J Clin Microbiol. 2021. PMID: 33980646. doi:10.1128/JCM.00706-21
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。